Epigenome wide study for the investigation of DNA methylation as therapeutic target and novel biomarker of pulmonary arterial hypertension.
Epigenome wide study for the investigation of DNA methylation as therapeutic target and novel biomarker of pulmonary arterial hypertension.
表观基因组广泛研究，研究 DNA 甲基化作为肺动脉高压的治疗靶点和新型生物标志物。
批准号：
452729
负责人：
Potus Francois
金额：
$62.98万
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2021
资助国家：
加拿大
项目状态：
未结题
起止时间：
2021-09-01 至 2026-09-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pulmonary arterial hypertension (PAH) is a lethal disease affecting the vessels in the lung and for which there is no cure. One of the reasons explaining the absence of treatment is that the mechanisms leading to the development of the disease are multifa
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金
